Serum S100B, NSE, and GRIA1 levels as neurological biomarkers in lead exposure


Firat Oguz E., YILMAZ F. M., Tutkun E., Yilmaz O. H., Ercan M., Sezer S.

Turkish journal of medical sciences, cilt.48, sa.3, ss.449-454, 2018 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.3906/sag-1511-174
  • Dergi Adı: Turkish journal of medical sciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.449-454
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet

Özet

Background/aim: The central nervous system is one of the major targets in lead exposure. Biomarkers for the diagnosis and follow-up of lead exposure have not been identified. In this study, serum S100B, neuron-specific enolase (NSE), and glutamate receptor 1 (GRIA1) levels were determined as possible biomarkers for lead neurotoxicity.